Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Leukemia

Free Subscription Articles published in Acta Haematol Retrieve available abstracts of 27 articles: HTML format Text format

Single Articles

October 2018
1. JIANG L, Deng T, Wang D, Xiao Y, et al
   Elevated Serum Exosomal miR-125b Level as a Potential Marker for Poor Prognosis in Intermediate-Risk Acute Myeloid Leukemia.
   Acta Haematol. 2018;140:183-192.
   PubMed     Text format     Abstract available
   
   
   September 2018
2. GIONA F, Santopietro M, Menna G, Putti MC, et al
   Real-Life Management of Children and Adolescents with Chronic Myeloid Leukemia: The Italian Experience.
   Acta Haematol. 2018;140:105-111.
   PubMed     Text format     Abstract available
   
   
   
3. NAESENS L, Devos H, Nollet F, Michaux L, et al
   Mediastinal Myeloid Sarcoma with TP53 Mutation Preceding Acute Myeloid Leukemia with a PICALM-MLLT10 Fusion Gene.
   Acta Haematol. 2018;140:97-104.
   PubMed     Text format     Abstract available
   
   
   
4. HA M, Kim JY, Han ME, Kim GH, et al
   TMEM18: A Novel Prognostic Marker in Acute Myeloid Leukemia.
   Acta Haematol. 2018;140:71-76.
   PubMed     Text format     Abstract available
   
   
   August 2018
5. ROZOVSKI U, Keating MJ, Estrov Z
   Why Is the Immunoglobulin Heavy Chain Gene Mutation Status a Prognostic Indicator in Chronic Lymphocytic Leukemia?
   Acta Haematol. 2018;140:51-54.
   PubMed     Text format     Abstract available
   
   
   
6. ABOU DALLE I, Cortes JE, Pinnamaneni P, Lamothe B, et al
   A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Relapsed/Refractory Acute Myeloid Leukemia.
   Acta Haematol. 2018;140:30-39.
   PubMed     Text format     Abstract available
   
   
   June 2018
7. PARK HS, Kim DY, Choi EJ, Lee JH, et al
   Blast Percentage of Bone Marrow Aspirate on Day 14 of Induction Chemotherapy Predicts Adult Acute Lymphoblastic Leukemia Treatment Outcomes.
   Acta Haematol. 2018;139:220-227.
   PubMed     Text format     Abstract available
   
   
   March 2018
8. SCHNEIDEWEND R, Hosking P, Brazauskas R, Peterson J, et al
   Early Fluorescence in situ Hybridization Assessment during Acute Myeloid Leukemia Induction Chemotherapy.
   Acta Haematol. 2018;139:171-175.
   PubMed     Text format    
   
   
   February 2018
9. SONG X, Peng Y, Wang X, Chen Y, et al
   Incidence, Survival, and Risk Factors for Adults with Acute Myeloid Leukemia Not Otherwise Specified and Acute Myeloid Leukemia with Recurrent Genetic Abnormalities: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database, 2001-201
   Acta Haematol. 2018;139:115-127.
   PubMed     Text format     Abstract available
   
   
   
10. BRUNNER AM
    No Mutation Left Behind: The Impact of Reporting Recurrent Genetic Abnormalities on Outcomes of Patients with Acute Myeloid Leukemia.
    Acta Haematol. 2018;139:128-130.
    PubMed     Text format    
    
    
    
11. BARON BW, Thirman MJ, Giurcanu MC, Baron JM, et al
    Quercetin Therapy for Selected Patients with PIM1 Kinase-Positive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pilot Study.
    Acta Haematol. 2018;139:132-139.
    PubMed     Text format     Abstract available
    
    
    
12. TANG X, Zhou J, Zhang J, Zhou LY, et al
    Low Expression of FUS1 Is Negatively Correlated with miR-378 and May Predict Adverse Prognoses in Acute Myeloid Leukemia.
    Acta Haematol. 2018;139:89-95.
    PubMed     Text format     Abstract available
    
    
    January 2018
13. NISCOLA P, Neri B, Morino L, de Fabritiis P, et al
    Monoclonal Gammopathy Responsive to Decitabine Given for Acute Myeloid Leukemia in a Frail Patient.
    Acta Haematol. 2018;139:58-59.
    PubMed     Text format    
    
    
    September 2017
14. LEADER A, Raanani P
    Switching-On Adherence in Chronic Myeloid Leukemia.
    Acta Haematol. 2017;138:138-139.
    PubMed     Text format    
    
    
    
15. MAEDA Y, Okamoto A, Kawaguchi SI, Konishi A, et al
    Improved Drug Adherence in Patients with Chronic Myeloid Leukemia in the Chronic Phase by Switching to Second-Generation Tyrosine Kinase Inhibitors.
    Acta Haematol. 2017;138:140-142.
    PubMed     Text format    
    
    
    
16. LIEBERMAN F, Villgran V, Normolle D, Boyiadzis M, et al
    Intracranial Hemorrhage in Patients Newly Diagnosed with Acute Myeloid Leukemia and Hyperleukocytosis.
    Acta Haematol. 2017;138:116-118.
    PubMed     Text format    
    
    
    July 2017
17. TIMMERMANS K, Leijte GP, Kox M, Scheffer GJ, et al
    Release of Danger-Associated Molecular Patterns following Chemotherapy Does Not Induce Immunoparalysis in Leukemia Patients.
    Acta Haematol. 2017;138:39-43.
    PubMed     Text format     Abstract available
    
    
    
18. ANAGNOSTOPOULOU E, Papanastasopoulou C, Papastamataki M, Kotsiou A, et al
    Serum Hyaluronic Acid Levels Are Altered in Acute Leukemia Patients: Potential Prognostic Implications.
    Acta Haematol. 2017;138:44-51.
    PubMed     Text format     Abstract available
    
    
    
19. HERNANDEZ-RIVAS JA, Gonzalez-Gascon Y Marin I
    Genetic Heterogeneity in Chronic Lymphocytic Leukemia: What Can Conventional Cytogenetics Add?
    Acta Haematol. 2017;138:31-32.
    PubMed     Text format    
    
    
    June 2017
20. CHANG H, Kuo MC, Tang TC, Lin TL, et al
    Clinical Features and Recurrence Pattern of Perianal Abscess in Patients with Acute Myeloid Leukemia.
    Acta Haematol. 2017;138:10-13.
    PubMed     Text format     Abstract available
    
    
    May 2017
21. PETERSON JF, Shah R, Kobrinski D
    Two Distinct BCL2 Rearrangements, Each Observed in 2 Independent Subclones, Evolving from a Founder Clone with Trisomy 12 in a Unique Case of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
    Acta Haematol. 2017;137:237-239.
    PubMed     Text format    
    
    
    April 2017
22. ZHAO H, Xu L, Yang Y, Shao J, et al
    Successful Management of Decitabine prior to Full-Dose Idarubicin and Cytarabine in the Treatment of Refractory/Recurrent Acute Myeloid Leukemia.
    Acta Haematol. 2017;137:195-200.
    PubMed     Text format     Abstract available
    
    
    
23. LI Y, Wang CL, Din B, Yu L, et al
    Continuing Imatinib Treatment for Chronic Myeloid Leukemia Patients Who Had Serious Adverse Events at the Onset of Therapy.
    Acta Haematol. 2017;137:158-162.
    PubMed     Text format    
    
    
    
24. PTACKOVA P, Petrackova M, Hindos M, Duskova M, et al
    Intracellular Cytokines Produced by Stimulated CD3+ Cells from Chronic Myeloid Leukemia Patients.
    Acta Haematol. 2017;137:148-157.
    PubMed     Text format     Abstract available
    
    
    January 2017
25. GUREVICH-SHAPIRO A, Tzadok S, Rosenberg A, Inbal A, et al
    Extended Small-Dose Platelet Transfusions in Multitransfused Hemato-Oncological Patients: A Single-Center Experience.
    Acta Haematol. 2017;137:183-190.
    PubMed     Text format     Abstract available
    
    
    
26. LIANG Y, Gao J, Wu D, Li S, et al
    Long-Term Remission following Autologous Hematopoietic Cell Transplantation in a Patient with Multiple Nonleukemic Myeloid Sarcoma and a Review of the Literature.
    Acta Haematol. 2017;137:117-122.
    PubMed     Text format     Abstract available
    
    
    
27. SCHNEIDEWIND L, Neumann T, Knoll F, Zimmermann K, et al
    Are the Polyomaviruses BK and JC Associated with Opportunistic Infections, Graft-versus-Host Disease, or Worse Outcomes in Adult Patients Receiving Their First Allogeneic Stem Cell Transplantation with Low-Dose Alemtuzumab?
    Acta Haematol. 2017;138:3-9.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: